Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS. 1995

J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
Tumorimmunology Program, German Cancer Research Center, Heidelberg.

The cell surface molecule APO-1/Fas(CD95), a member of the Tumor Necrosis Factor (TNF) receptor/Nerve Growth Factor (NGF) receptor superfamily mediates apoptosis upon cross-linking by agonistic antibodies or its ligand. Recent findings suggest that APO-1/Fas(CD95) and its ligand are the key molecules for antigen receptor-induced apoptosis in activated mature T cells. Here we propose a mechanism for antigen receptor-induced apoptosis of activated T cells via APO-1 ligand mediated autocrine suicide. This mechanism may also contribute to the depletion of CD4+ T cells in AIDS.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017475 Receptors, Nerve Growth Factor Cell surface receptors that bind NERVE GROWTH FACTOR; (NGF) and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR. NGF Receptors,Nerve Growth Factor Receptors,Neurotrophic Factor Receptor,Neurotrophin Receptor,Receptors, NGF,Receptors, Neurotrophin,Neurotrophin Receptors,Receptors, Neurotrophic Factor,Neurotrophic Factor Receptors,Receptor, Neurotrophic Factor,Receptor, Neurotrophin

Related Publications

J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
October 1998, Current opinion in immunology,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
January 1999, Advances in immunology,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
December 1996, Leukemia & lymphoma,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
August 1998, Experimental hematology,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
June 2001, Journal of leukocyte biology,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
April 2000, Experimental cell research,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
August 1995, Biochemical and biophysical research communications,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
March 2000, Journal of pediatric surgery,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
March 1999, European journal of immunology,
J Dhein, and H Walczak, and M O Westendorp, and C Bäumler, and K Stricker, and R Frank, and K M Debatin, and P H Krammer
January 1999, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Copied contents to your clipboard!